The association between allogeneic perioperative blood transfusion on tumour recurrence and survival in patients with advanced ovarian cancer

Transfusion Medicine

Volumn 22, Issue 2, 2012, Pages 97-103

  de Oliveira, G S ^a   Schink, J C ^a   Buoy, C ^a   Ahmad, S ^a   Fitzgerald, P C ^a   McCarthy, R J ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Allogeneic transfusion; Ovarian cancer; Survival

Indexed keywords

ALTRETAMINE; BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FRESH FROZEN PLASMA; GEMCITABINE; IFOSFAMIDE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD TRANSFUSION; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; OVARY CANCER; RETROSPECTIVE STUDY;

AGED; BLOOD TRANSFUSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PERIOPERATIVE CARE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84858795986     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2011.01122.x     Document Type: Article

References (26)

1. Amato, A. & Pescatori, M. (2006) Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database System Review, 25. Art. No.: CD005033. DOI: 10.1002/14651858.CD005033.pub2.
2. Blajchman, M.A. & Bordin, J.O. (1995) The tumor growth-promoting effect of allogeneic blood transfusions. Immunological Investigations, 24, 311-317.
3. Bontkes, H.J. Walboomers, J.M., Meijer, C.J., Helmerhorst, T.J. & Stern, P.L. (1998) Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet, 351, 187-188.
4. Bordin, J.O. Bardossy, L. & Blajchman, M.A. (1994) Growth enhancement of established tumors by allogeneic blood transfusion in experimental animals and its amelioration by leukodepletion: the importance of the timing of the leukodepletion. Blood, 84, 344-348.
5. Brand, A. & Houbiers, J.G.A. (1999) Clinical studies of blood transfusion and cancer. In: Immunomodulatory Effects of Blood Transfusion (eds Vamvakas, E.C. Blajchman, M.A.), 145-190. AABB Press, Bethesda, MD.
6. de Oliveira, G.S. Jr., Ahmad, S., Schink, J.C. Singh, D.K. Fitzgerald, P.C. & McCarthy, R.J. (2011) Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Regional Anesthesia and Pain Medicine, 36, 271-277.
7. Finn, O.J. (2008) Cancer immunology. The New England Journal of Medicine, 358, 2704-2715.
8. Foster, R.S. Jr., Costanza, M.C. Foster, J.C. Wanner, M.C. & Foster, C.B. (1985) Adverse relationship between blood transfusions and survival after colectomy for colon cancer. Cancer, 55, 1195-1201.
9. Heal, J.M. Chuang, C. & Blumberg, N. (1988) Perioperative blood transfusions and prostate cancer recurrence and survival. American Journal of Surgery, 156, 374-380.
10. Heintz, A.P. Odicino, F. Maisonneuve, P. Beller, U., Benedet, J.L. Creasman W.T., Ngan, H.Y. & Pecorelli, S. (2003) Carcinoma of the ovary. International Journal of Gynaecology and Obstetrics, 83, 135-166.
11. Høgdall, E.V. Christensen, L. Kjaer, S.K. Blaakaer, J. Kjaerbye-Thygesen, A. Gayther, S. Jacobs, I.J. & Høgdall, C.K. (2007) CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients. From The Danish "MALOVA" Ovarian Cancer Study. Gynecologic Oncology, 104, 508-515.
12. Hyman, N.H. Foster, R.S. Jr., DeMeules, J.E. & Costanza, M.C. (1985) Blood transfusions and survival after lung cancer resection. American Journal of Surgery, 149, 502-507.
13. Kao, K.J. (1996) Induction of humoral immune tolerance to major histocompatibility complex antigens by transfusions of UVB-irradiated leukocytes. Blood, 88, 4375-4382.
14. Jemal, A. Siegel, R. Ward, E. Hao, Y. Xu, J. & Thun, M.J. (2009) Cancer statistics 2009. CA: A Cancer Journal for Clinicians, 59, 225-249.
15. Jones, K.R. & Weissler, M.C. (1990) Blood transfusion and other risk factors for recurrence of cancer of the head and neck. Archives of Otolaryngology - Head and Neck Surgery, 116, 304-309.
16. Lange, M.M. van Hilten, J.A. van de Watering, L.M. Bijnen, B.A. Roumen, R.M. Putter, H. Brand, A. & van de Velde, C.J. (2009) Cooperative clinical investigators of the Cancer Recurrence And Blood Transfusion (CRAB) study and the Transfusion Associated Complications = Transfusion Induced Complications? (TACTIC) study. Leucocyte depletion of perioperative blood transfusion does not affect long-term survival and recurrence in patients with gastrointestinal cancer. British Journal of Surg, 96, 734-740.
17. Magee, C.C. & Sayegh, M.H. (1997) Peptide-mediated immunosuppression. Current Opinion in Immunology, 9, 669-675.
18. Ojima, T. Iwahashi, M. Nakamori, M. et al. (2009) Association of allogeneic blood transfusions and long-term survival of patients with gastric cancer after curative gastrectomy. Journal of Gastrointestinal Surgery, 13, 1821-1830.
19. Rossi, A.C. Di Vagno, G. Cormio, G. Cazzolla, A. Stefanelli, S., D'Elia, E. & Selvaggi, L.A. (2004) Retrospective study of preoperative CA 125 levels in 82 patients with ovarian cancer. Archives of Gynecology and Obstetrics, 269, 263-265.
20. Skånberg, J. Lundholm, K. & Haglind, E. (2007) Effects of blood transfusion with leucocyte depletion on length of hospital stay, respiratory assistance and survival after curative surgery for colorectal cancer. Acta Oncologica, 46, 1123-1130.
21. Tartter, P.I. Burrows, L. Papatestas, A.E. Lesnick, G. & Aufses, A.H. Jr. (1985) Perioperative blood transfusion has prognostic significance for breast cancer. Surgery, 97, 225-230.
22. Vamvakas, E.C. & Blajchman, M.A. (2007) Transfusion-related immunomodulation (TRIM): an update. Blood Reviews, 21, 327-348.
23. Winter, W.E. III, Maxwell, G.L. Tian, C. et al. (2007) Gynecologic Oncology Group Study. Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. Journal of Clinical Oncology, 25, 3621-3627.
24. Wu, H.S. & Little, A.G. (1988) Perioperative blood transfusions and cancer recurrence. Journal of Clinical Oncology, 6, 1348-1354.
25. Yamamoto, J. Kosuge, T. Takayama, T. et al. (1994) Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy. Surgery, 115, 303-309.
26. Zivanovic, O. Aldini, A. Carlson, J.W. & Chi, D.S. (2009) Advanced cytoreductive surgery: American perspective. Gynecologic Oncology, 114, S3-S9.